The Practical Reality of Agentic AI in Healthcare Revenue Cycle Management

The revenue cycle keeps collecting promises. RPA was going to change everything. So was NLP. Then generative AI shifted the conversation entirely. Now it’s agentic AI, and the difference this time is that some of it is actually landing.

Not all of it. Not even most of it. But enough is working in production environments to make this moment genuinely different from what came before.

What It Actually Means to Act

There’s a version of “agentic AI” that gets used in product decks to describe any AI that does more than one thing. That version isn’t worth discussing.

A real AI agent doesn’t wait for someone to interpret its output and decide what to do next. It reads a clinical note, identifies a missing authorization, navigates the payer portal, submits the request. If the request comes back denied, it pulls the relevant documentation, builds the appeal, routes it appropriately. No ticket opened. No queue. No staff member clicking through six screens to get there.

In RCM, that matters for a specific reason. The work is deeply non-linear. A prior authorization request can touch four different systems before it resolves. Payer requirements change. Documentation quality varies by provider, by specialty, by week. A system that only follows a fixed script won’t hold up in that environment for long.

Where Results Are Actually Showing Up

Prior authorization comes up first in almost every honest conversation about this, and the reason is structural. It’s one of the most document-heavy, rules-intensive tasks in the cycle. The American Medical Association’s 2024 Prior Authorization Physician Survey found that 27% of physicians report their prior authorization requests are often or always denied, and physicians complete an average of 39 prior authorizations per week, each one pulling time directly away from patient care. That’s not a clinical failure. That’s a documentation and workflow failure, which is exactly the kind of problem agentic systems are built for.

Agents validate eligibility, map clinical documentation against payer criteria, track submission status, surface missing information before a human reviewer has to get involved. The task structure suits them. Repetitive information gathering, predictable matching rules, clear end states.

Proactive claim scrubbing is showing similar traction. Rather than chasing denials after a rejection, agents run pre-submission audits that catch coding errors, documentation gaps, and authorization mismatches before anything reaches a payer. According to HFMA’s September 2025 survey of 272 healthcare executives, organizations that have deployed AI and automation in the revenue cycle report measurable reductions in claim error rates and faster reimbursement timelines as their top two outcomes. That kind of upstream correction is where a lot of the real financial recovery is happening.

The Honest Picture

An HFMA-FinThrive survey from May 2025 found that 63% of healthcare organizations are already using AI and automation somewhere in their revenue cycle. That sounds like real momentum. And it is, with an asterisk.

“Some form of AI” can cover a lot of ground. For many organizations, it means a scoped agent handling one specific task, typically prior authorization or denial appeals, in one corner of the cycle. That’s a legitimate starting point. But the gap between that and a multi-agent workflow covering eligibility, coding, claims, and reconciliation end to end is not a small gap. As explored in Rethinking Revenue Cycle Modernization in the Age of AI, the structural barriers to full-cycle transformation run deeper than most technology roadmaps acknowledge.

Most vendor conversations skip past that gap pretty quickly. The fully touchless revenue cycle is a reasonable direction to plan toward. It’s just not where most organizations are right now, and treating it as achievable in the near term tends to create problems during deployment.

Why Pilots Stall

Agentic AI rarely fails during testing. Pilots almost always look promising. The use case is narrow, the data is reasonably clean, and someone is paying close attention to what the agent does.

Production is different. Payer rules change without notice. EHR documentation quality shifts by department, provider, and specialty. Edge cases multiply faster than anticipated. When nobody has designed a clear escalation path for when an agent hits something outside its scope, the workflow either stalls or keeps moving with errors that take weeks to surface.

Scaling from pilot to production is a fundamentally different problem than making the pilot work. Organizations that treat them as the same problem usually discover that during deployment, not before it. That’s one reason why the broader AI adoption landscape has been struggling with production failures well beyond healthcare.

The Infrastructure Problem

Agentic AI performs well when it has clean, consistent, connected data to work with. That qualifier is more significant than it sounds.

Most mid-to-large health systems run fragmented EHR environments with inconsistent field definitions across platforms, payer portals with different access rules, and documentation quality that varies by specialty and individual provider. These aren’t edge cases. They’re the standard operating environment. The challenge is closely related to a broader pattern of accumulated technical and structural debt that shapes how healthcare systems respond to new AI demands.

Messy data doesn’t always cause obvious failures. More often, agents start escalating exceptions they shouldn’t need to flag, and outputs look correct on the surface while quietly carrying errors that take weeks to surface. The technology, in most of those cases, is doing exactly what it was designed to do. What isn’t holding up is the infrastructure it’s sitting on.

Getting that layer right before scaling agents is the unglamorous part of this work, and also the part that doesn’t get enough attention in vendor roadmaps.

What Changes When It Actually Works

The AMA’s 2024 Prior Authorization Physician Survey tells part of this story clearly: 93% of physicians say prior authorization negatively impacts patient outcomes, and 94% say it delays access to necessary care. When agents absorb that documentation and submission burden, clinical staff get measurable time back. The argument for agentic AI in RCM isn’t only about cost-per-claim. It’s also about where staff time actually goes, and whether that’s sustainable.

The organizations moving furthest with this aren’t necessarily the ones with the largest technology budgets. They tend to be the ones that started narrow, built human oversight into the workflow from day one, and spent the first months in production learning from what the agent got wrong rather than only celebrating what it got right. Slower than the pitch suggests. Also more durable.

Where This Is Headed

HFMA’s March 2026 report on healthcare margin and AI investment noted that revenue cycle leaders are moving from exploratory pilots to active investment in AI as a primary lever for margin protection heading into the rest of 2026. That’s not speculative. Those are budget decisions already being made.

What’s less settled is what production at scale actually looks like when EHR fragmentation is real, payer rules keep shifting, and the workforce models haven’t fully caught up to what autonomous agents change about the job. The next 18 months will answer more of those questions than the previous three years combined. Worth paying close attention to.